Recombinant human erythropoietin(rhepo) (DrugBank: Erythropoietin)
10 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 1 |
6 | パーキンソン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
18 | 脊髄小脳変性症(多系統萎縮症を除く。) | 0 |
22 | もやもや病 | 0 |
46 | 悪性関節リウマチ | 0 |
47 | バージャー病 | 0 |
70 | 広範脊柱管狭窄症 | 0 |
95 | 自己免疫性肝炎 | 0 |
96 | クローン病 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03835507 (ClinicalTrials.gov) | June 20, 2016 | 8/8/2018 | Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis | Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Drug: recombinant human erythropoietin(rhEPO) | Hanyang University Seoul Hospital | NULL | Recruiting | 25 Years | 80 Years | All | 64 | Phase 1;Phase 2 | Korea, Republic of |